Slone Partners Places Sotirios Karathanasis as Chief Science Officer at Enveda Biosciences
Share Article
Respected industry leader will spearhead company’s small molecule drug discovery portfolio
“Dr. Karathanasis is a highly accomplished and respected scientist, researcher, and innovator with broad drug discovery and development experience whose intellect and insights will advance Enveda’s impressive drug discovery portfolio,” said Slone Partners President Tara Kochis-Stach. SOUTH RIDING, Va. (PRWEB) April 29, 2021
Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Sotirios Karathanasis, Ph.D. as the new Chief Science Officer (CSO) at Enveda Biosciences. In his new role, Dr. Karathanasis will lead the company’s small molecule drug discovery portfolio and work with Enveda’s preclinical team to advance the compan
Slone Partners Places Mark Capone as Non-Executive Board Member at Abcam prweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prweb.com Daily Mail and Mail on Sunday newspapers.
Slone Partners Places Phil Paik, Ph.D., as Vice President, Platform Development, at Molecular Assemblies
Share Article
Experienced industry leader will advance breakthrough technology into a commercial platform
“Dr. Paik is an experienced industry leader who brings a track record of success over many years,” said Slone Partners President Tara Kochis-Stach. SOUTH RIDING, Va. (PRWEB) December 17, 2020
Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Phil Paik, Ph.D., as Vice President, Platform Development, at Molecular Assemblies, Inc. In his new role, Dr. Paik’s deep expertise in microfluidics and product development will be applied in advancing Molecular Assemblies’ breakthrough enzymatic DNA synthesis technology into a commercial platform.
Slone Partners Places Will Geist as Chief Operating Officer at Quanterix
Share Article
Geist brings operational experience to Quanterix as company scales to support rapid growth.
“Will Geist is an extraordinarily talented and accomplished executive with an impressive track record of success in operations, sales, marketing, and business development leadership roles,” said Slone Partners CEO Leslie Loveless. SOUTH RIDING, Va. (PRWEB) December 15, 2020
Slone Partners, a nationwide executive search firm for life science, biotechnology, and diagnostics companies, has announced the placement of Will Geist as Chief Operating Officer (COO) at Quanterix Corporation. In his new role, Geist will build on Quanterix’ track record of strong execution as the company expands globally and continues to disrupt pharmaceutical development and diagnostics research.